China Approves Obesity Drug for Severe Fatty Liver Disease
China has approved an obesity drug for the treatment of severe fatty liver disease. The approval arrives amid heightened competition among pharmaceutical companies racing to secure approval for weight-loss medications that address a broader range of illnesses. The source does not name the specific drug, manufacturer, or approval date.
Key facts
- China approved an obesity drug for severe fatty liver disease
- The approval follows increased competition among pharmaceutical companies
- Companies are pushing to attain weight-loss medication approval
- The goal is to treat a wider range of illnesses
Entities
Locations
- China